Home Companies Merck & Co

Merck & Co

Latest

Antibodies

Absci Pursues Google-Sized Ambitions in Drug Discovery, Manufacturing

Cancer

StockWatch: Moderna Cancer Vaccine Propels 72% Surge

Lung Cancer

StockWatch: Summit Nearly Triples on Up-to-$5B Cancer Alliance with Akeso

Eye Disorders

StockWatch: Failed Trial Sinks NGM Bio; Will Merck Opt Into Eye Disorder Drug?

mRNA

StockWatch: Moderna Shares Rise as Merck Opts Into Cancer Vaccine

Immuno-oncology

StockWatch: Checkmate Shares Quadruple on Regeneron Buyout

Immuno-oncology

Regeneron to Acquire Checkmate for $250M, Expanding Cancer I/O Pipeline

Vaccine Development

Patch Position: Vaxxas Licenses UT Austin Vaccine for Clinical Trials

Small Molecules

Looking Beyond the Curve: Merck Inks Up-to-$1.7B Small Molecule Partnership

HBV

And Then There Were Four: VBI Scores First FDA Approval with...

Coronavirus

“Game Changer:” After Vaccines, Pfizer Stakes Claim in COVID-19 Drugs, Too

Merck & Co

Merck to Seek FDA EUA for COVID-19 Pill after Positive Phase...

Merck & Co

Merck & Co. to Acquire Acceleron for $11.5B

Merck & Co

‘Manufacturing-First Approach’ Pays Off for Cell Therapy Developer Artiva

Merck & Co

Merck Halves COVID-19 Pipeline; Halts Two Vaccines, Continues Two Drugs

12 3...5 Page 1 of 5